Overview: CMV Qualitative PCR TestIntroduction: The CMV Qualitative PCR Test detects cytomegalovirus DNA, confirming active infection causing fever or organ issues. Following 2023 IDSA guidelines, it uses PCR for high specificity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in virology for patients with suspected active CMV infections.
Other Names: CMV Qual PCR Assay, Cytomegalovirus DNA Detection Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: CMV PCR testing began in the 1990s with molecular diagnostics. Qualitative PCR emerged in the 2000s, improving detection accuracy for active infections.
Purpose: Confirms active CMV infection, guides antiviral therapy, and monitors DNA presence in patients with fever or organ issues.
Test Parameters: 1. Cytomegalovirus DNA
Pretest Condition: No fasting required. Collect whole blood, serum, plasma, CSF, urine, amniotic fluid, or saliva at any time. Report symptoms like fever or organ dysfunction, and list immunocompromising conditions.
Specimen: 2-5 mL whole blood (EDTA), 2-5 mL serum (SST), 2-4 mL plasma (EDTA), 1-2 mL CSF (sterile container), 5-20 mL urine (sterile container), 1-2 mL amniotic fluid (sterile container), or 1-2 mL saliva (sterile container). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fever, organ dysfunction, or immunocompromised states (e.g., HIV, transplant). Include current medications, especially antivirals.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antiviral therapy.
Procedural Considerations: Uses qualitative PCR to detect CMV DNA. Results are available in 3-5 days, supporting clinical decisions.
Factors Affecting Result Accuracy: Low viral load or contamination can affect results. Improper storage reduces sensitivity.
Clinical Significance: Positive DNA results confirm active CMV infection, prompting antiviral therapy. Negative results may require repeat testing or IgM testing.
Specialist Consultation: Consult an infectious disease specialist or transplant specialist for result interpretation.
Additional Supporting Tests: CMV IgG/IgM, quantitative PCR, or organ imaging to confirm infection or assess complications.
Test Limitations: False negatives may occur with low viral load. Results require clinical correlation.
References: IDSA CMV Guidelines, 2023; Clinical Infectious Diseases, Ljungman P, 2022.
